NIMG-30. PATHOLOGICAL VALIDATION OF CONTRAST ENHANCEMENT AT AUTOPSY BETWEEN PATIENTS TREATED AND UNTREATED WITH CHEMOTHERAPY AND RADIATION

MLA

Wade M. Mueller, et al. Nimg-30. Pathological Validation of Contrast Enhancement at Autopsy between Patients Treated and Untreated with Chemotherapy and Radiation. Nov. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e2b6b6043d81c59cbba8191c4a9d8c17&authtype=sso&custid=ns315887.

APA

Wade M. Mueller, Allison Lowman, Michael Brehler, Peter S. LaViolette, Anjishnu Banerjee, Savannah Duenweg, Fitzgerald Kyereme, John Sherman, Elizabeth J. Cochran, Jennifer Connelly, & Samuel Bobholz. (2021). Nimg-30. Pathological Validation of Contrast Enhancement at Autopsy between Patients Treated and Untreated with Chemotherapy and Radiation.

Chicago

Wade M. Mueller, Allison Lowman, Michael Brehler, Peter S. LaViolette, Anjishnu Banerjee, Savannah Duenweg, Fitzgerald Kyereme, et al. 2021. “Nimg-30. Pathological Validation of Contrast Enhancement at Autopsy between Patients Treated and Untreated with Chemotherapy and Radiation,” November. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e2b6b6043d81c59cbba8191c4a9d8c17&authtype=sso&custid=ns315887.